Therapeutic Delivery · 2020 · 29 citations · 30 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryNanoparticle Drug DeliveryTheranosticsCancer NanomedicineDrug EncapsulationNanomedicineNanoparticle CharacterizationNanoparticle FormulationsTheranostic NanoparticlesEncapsulation EfficiencyLiposomesNanocarrier Encapsulation EfficiencyNanoparticle CytotoxicityNanoparticlesSolvent InjectionTargeted LiposomesUpconversion Nanoparticles
Aim: This work focused on the development of transferrin-conjugated theranostic liposomes consisting of docetaxel (DXL) and upconversion nanoparticles for the diagnosis and treatment of gliomas. Materials & methods: Upconversion nanoparticles and docetaxel-loaded theranostic liposomes were prepared by a solvent injection method. Formulations were analyzed for physicochemical properties, encapsulation efficiency, drug release, elemental analysis, cytotoxicity and fluorescence. Results: The particle size was around 200 nm with spherical morphology and an encapsulation efficiency of up to 75.93%, was achieved for liposomes with an in vitro drug release of 71.10%. The IC50 values demonstrated enhanced cytotoxicity on C6 glioma cells with targeted liposomes in comparison with nontargeted liposomes. Conclusion: Prepared theranostic liposomes may be promising for clinical validation after an in vitro and in vivo evaluation on cell lines and animals, respectively.
30
Karsten Ulbrich, Telli Hekmatara, Elisabeth Herbert et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2008 · 584 citations
Jing Zhou, Yun Sun, Xiaoxia Du et al. · Biomaterials · 2010 · 544 citations
Natural Sciences, Biomedical Engineering, Materials Science +16